First Heartland Consultants’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$205K Buy
+1,441
New +$219K 0.01% 571
2023
Q2
– Sell
-4,566
Closed -$420K – 389
2023
Q1
$420K Buy
4,566
+13
+0.3% +$1.14K 0.06% 228
2022
Q4
$413K Buy
+4,553
New +$383K 0.07% 227
2016
Q3
– Sell
-3,775
Closed -$279K – 330
2016
Q2
$279K Buy
+3,775
New +$261K 0.03% 240
2014
Q4
– Sell
-2,375
Closed -$200K – 264
2014
Q3
$200K Buy
+2,375
New +$192K 0.09% 232

Other funds holding NVS

First Heartland Consultants's NVS Position: Q3 2026 in Review

First Heartland Consultants opened a new position in Novartis (NVS) in Q3 2026: 1,441 shares worth $205K. The stake represents 0.01% of the portfolio and ranks #571 among its holdings. This is a return to the name: First Heartland Consultants previously reported a position in NVS as recently as Q1 2023.

First Heartland Consultants first reported a position in NVS in Q3 2014 and has held it in 5 quarters since. The position peaked at $420K in Q1 2023. 83 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • First Heartland Consultants held 1,441 shares of Novartis worth $205K as of Q3 2026.
  • Novartis was a new First Heartland Consultants position in Q3 2026.
  • Novartis made up 0.01% of First Heartland Consultants's portfolio in Q3 2026, its #571 holding.
  • First Heartland Consultants first reported a position in Novartis in Q3 2014 and has held it in 5 quarters since.
  • First Heartland Consultants's Novartis position peaked at $420K in Q1 2023.
  • 83 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on First Heartland Consultants's 13F filing for Q3 2026, filed 8 Oct 2026.